The Centre involves academics from across the University's faculties of Engineering, Medicine and Health, and Biological Sciences, its schools of Chemistry and Design and the Leeds University Business School.
Our Centre will provide postgraduate research and training for 50 students, to research, develop and deliver regenerative therapies and devices, which can repair or replace diseased tissues and restore normal tissue function. By using novel scaffolds in conjunction with the patient's own (autologous) cells, effective acellular regenerative therapies for tissue repair can be developed at a lower cost, reduced time and reduced risk, compared to alternative and more complex cell therapy approaches.
We have identified with our partners in industry and the Health Service, a gap in high level skills and capability of postgraduates in this area, who have appropriate multidisciplinary training to address the challenges in applied research, innovation, evaluation, manufacturing, and translation of regenerative therapies and devices.
This emerging sector needs a new type of multidisciplinary engineer with research and training in applied physical sciences and life sciences, advanced engineering methods and techniques, supported by training in innovation, regulation, health economics and business, and with research experience in the field of regenerative therapies and devices.
CDT TERM iMBE will create an enhanced multidisciplinary research training environment, by bringing together academics, industry and healthcare professionals in a unique research and innovation ecosystem, to train and develop the medical and biological engineers of the future, in the emerging field of regenerative therapies and devices.